The recombinant Nora vaccine, produced by Iran’s Baqiyatallah University of Medical Sciences, has received permission to be used for vaccination of people against Covid-19 after clinical trials.
That’s according to Dr. Abolghassemi, president of the university.
Abolghassemi said over the past years, Iran has gone through many hardships and the sanctions put a lot of pressure on its people.
He however added that thanks to efforts by Iranian scientists, the technical know-how of producing a recombinant protein vaccine became indigenous.
“The vaccines reduce morbidity and mortality, and this is the result of efforts by Iranian scientists,” he said.
Abolghassemi said today, the sense of self-confidence among Iranian researchers who are able to do difficult work has been strengthened.
He thanked all those who participated in the clinical trial of Nora vaccine.
Iran has until now administered over 143 million doses of jabs including many homegrown ones.
For the first time in Iran's aviation history, a flight carrying an all-female crew and…
Tehran’s Cyber Police Chief, Brigadier General Davood Moazzami Goudarzi, announced a crackdown on individuals causing…
Doha will stop gas shipments to the EU if member states enforce new legislation on…
At least 15,000 British soldiers left the country's Armed Forces between November 2023 and October…
Journalists have identified the names of 84,761 Russian soldiers who died during the war in…
The United States Navy has inadvertently shot down its own F/A-18 fighter jet in a…